ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
4.100
+0.050 (1.23%)
Oct 30, 2026, 4:00 PM EDT - Market closed
ImageneBio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 94.68 | 94.53 | 12.12 | 15.32 |
Short-Term Investments | 41.48 | 40.82 | - | 10.15 |
Cash & Short-Term Investments | 136.15 | 135.35 | 12.12 | 25.47 |
Cash Growth | 2161.30% | 1016.92% | -52.43% | - |
Other Receivables | - | 1.3 | 0.08 | 0.22 |
Receivables | - | 1.3 | 0.08 | 0.22 |
Prepaid Expenses | 4.46 | 1.51 | 0.21 | 0.2 |
Other Current Assets | 0.5 | 2.14 | 0.06 | - |
Total Current Assets | 141.11 | 140.29 | 12.47 | 25.9 |
Property, Plant & Equipment | 0.52 | 0.79 | 0.56 | 4.28 |
Long-Term Investments | - | - | 0.94 | - |
Long-Term Deferred Charges | - | - | 1.89 | - |
Other Long-Term Assets | 7.85 | 4.88 | 0.07 | 1.07 |
Total Assets | 152.05 | 152.98 | 15.92 | 31.25 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 0.98 | 1.44 | 5.29 | 5.88 |
Accrued Expenses | 3.68 | 7.53 | 3.46 | 3.13 |
Short-Term Debt | - | - | 7.5 | - |
Current Portion of Leases | 1.91 | 2.26 | 0.31 | 0.42 |
Current Unearned Revenue | - | - | 0.65 | 0.07 |
Total Current Liabilities | 6.57 | 11.23 | 17.21 | 9.49 |
Long-Term Leases | - | 0.71 | 0.24 | 0.57 |
Long-Term Unearned Revenue | - | - | - | 0.07 |
Other Long-Term Liabilities | 3.4 | 7.89 | - | - |
Total Liabilities | 9.97 | 19.84 | 17.45 | 10.13 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 0.01 | 0.01 | 0 | 0.01 |
Additional Paid-In Capital | 392.96 | 363.09 | 2.16 | - |
Retained Earnings | -250.85 | -230.05 | -179.9 | -143.33 |
Comprehensive Income & Other | -0.05 | 0.09 | -1.79 | -1.75 |
Total Common Equity | 142.07 | 133.14 | -179.53 | -145.08 |
Shareholders' Equity | 142.07 | 133.14 | -1.53 | 21.12 |
Total Liabilities & Equity | 152.05 | 152.98 | 15.92 | 31.25 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 1.91 | 2.98 | 8.05 | 0.98 |
Net Cash (Debt) | 134.24 | 132.37 | 4.07 | 24.49 |
Net Cash Growth | - | 3152.43% | -83.38% | - |
Net Cash Per Share | 12.12 | 24.37 | 1.86 | 0.08 |
Filing Date Shares Outstanding | 11.35 | 11.18 | 462.11 | 320.91 |
Total Common Shares Outstanding | 11.28 | 11.18 | 462.11 | 320.91 |
Working Capital | 134.54 | 129.05 | -4.74 | 16.41 |
Book Value Per Share | 12.60 | 11.91 | -0.39 | -0.45 |
Tangible Book Value | 142.07 | 133.14 | -179.53 | -145.08 |
Tangible Book Value Per Share | 12.60 | 11.91 | -0.39 | -0.45 |
Machinery | - | - | 0.11 | 3.19 |
Leasehold Improvements | - | - | 0.23 | 3.3 |